Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 5 Prostatic Neoplasms 4 Glioma 4 Lung Neoplasms 3 Epstein-Barr Virus Infections 3 Astrocytoma 3 Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Cytomegalovirus Infections 2 Breast Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Stomatitis 1 Sezary Syndrome 1 Recurrence 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1

Interventions

Gemcitabine 677 130-nm albumin-bound paclitaxel 197 Fluorouracil 184 Oxaliplatin 173 Albumin-Bound Paclitaxel 151 Capecitabine 137 Leucovorin 129 Irinotecan 111 Radiotherapy 95 Taxes 83 pembrolizumab 80 Cisplatin 71 Erlotinib Hydrochloride 69 Radiosurgery 67 Nivolumab 56 Bevacizumab 54 Drug Therapy 52 Cyclophosphamide 48 Magnetic Resonance Spectroscopy 45 folfirinox 42 Docetaxel 41 Cetuximab 40 irinotecan sucrosofate 36 Specimen Handling 36 S 1 (combination) 36 Biopsy 30 Radiation 29 Paclitaxel 29 Ipilimumab 27 Surgical Procedures, Operative 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Neoplasms × Valacyclovir × Clear all

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡